Full name
NOWY SZPITAL W SZPROTAWIE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
NOWY SZPITAL W SZPROTAWIE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. HENRYKOWSKA 1, 67-300 SZPROTAWA
TAX ID9552268107
Rate company:
NOWY SZPITAL W SZPROTAWIE SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID9552268107
KRS0000310791
Share capital795,400.00 zł
address
UL. HENRYKOWSKA 1, 67-300 SZPROTAWA
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
9552268107
REGON
320592406
KRS
0000310791
Legal form
limited liability company
Register Address
UL. HENRYKOWSKA 1, 67-300 SZPROTAWA
Date of registration in KRS
2008-07-29
Date of commencement of economic activity
2008-07-29
Act signature
ZG.VIII NS-REJ.KRS/3920/24/778/ADE
Pkd codes
86.10.Z - Hospital activities
47.73.Z - Retail sale of pharmaceutical products
86.21.Z - General medical practice
86.22.Z - Specialist medical practice
86.23.Z - Dental practice
86.90.A - Healthcare
86.90.B - Healthcare
86.90.C - Healthcare
86.90.D - Healthcare
86.90.E - Healthcare
Payer VAT status
Active
Vat list bank account(s)
PL79 1600 1462 1736 6022 5000 0004 
PL52 1600 1462 1736 6022 5000 0005 PL09 1600 1462 1736 6022 5000 0003 PL63 1600 1462 1736 6022 5000 0001 Show more bank accounts from VAT list (1)
EU grants
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2017 | 2018 | ||
|---|---|---|---|
M PLN | M PLN | % | |
Gross profit (loss)  | -0 | -0,7 | -2003,3 |
EBITDA | 0,1 | -0,5 | -604,3 |
Short time liabilities | 2,3 | 3,2 | 38,2 |
Equity capital | -1,4 | -2,1 | -47,8 |
Operating profit (EBIT) | -0 | -0,7 | -4781,6 |
Assets | 1,6 | 2 | 21,4 |
Net profit (loss) | -0 | -0,7 | -2003,3 |
Cash | 0,1 | 0,1 | 6,7 |
Net income from sale | 10 | 10,1 | 1,2 |
Liabilities and provisions for liabilities | 3 | 4,1 | 33,7 |
Working assets | 1,1 | 1,1 | -3,3 |
Depreciation | 0,1 | 0,1 | 7,6 |
% | % | p.p. | |
Profitability of capital | 2,3 | 32,3 | 30 |
Equity capital to total assets | -87,5 | -106,5 | -19 |
Gross profit margin | -0,3 | -6,7 | -6,4 |
EBITDA Margin | 1,1 | -5,3 | -6,4 |
Days | Days | Days | |
Short term commitment turnover cycle | 84 | 115 | 31 |
Financial statements
01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdf01-01-2023 - 31-12-2023
Auditor's opinion / report on the audit of the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Annual financial report
Download xades01-01-2023 - 31-12-2023
Annual financial report
Download pdfShow more (3)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.